Christiani Amorim | Medicine and Health Sciences | Hypothesis Achievement Award

Christiani Amorim | Medicine and Health Sciences | Hypothesis Achievement Award

Assoc Prof Dr Christiani Amorim, Université catholique de Louvain, Belgium

Publication profile

google scholar

Education

Assoc. Prof. Dr. Christiani Amorim holds a Ph.D. in Veterinary Medicine from the Federal University of Santa Maria (2006), an M.Sc. in Production and Reproduction in Small Ruminants from the State University of Ceará (1998), and a B.Sc. in Veterinary Medicine from the State University of Ceará (1995).

Work Experience

Dr. Amorim is currently a Professor and Honorary FNRS Research Associate at the Catholic University of Louvain in Brussels, Belgium, and the Chief Scientific Officer at ProFaM in Birmingham, UK. She has held numerous academic and research roles, including Adjunct Faculty at Southern Illinois University (2021-2024) and FNRS Research Associate at the Catholic University of Louvain (2014-2020).

Teaching

She has been lecturing in various subjects since 2023 at Université Catholique de Louvain, including courses in reproductive systems, histology, and pathophysiology. Previously, she taught veterinary obstetrics and special topics in animal biology at the University of Brasília.

Commission of Trust

Dr. Amorim has served on multiple committees, including as a member of the Conseil Equity, Diversity, Inclusion, and as Director of the Research Pole in Physiopathology of Reproduction at Université Catholique de Louvain. She was also the President of the Society of Low Temperature Biology from 2020-2023.

Event Organization

She has organized and participated in numerous international conferences and workshops, such as CRYO2024 and the 61st Annual Meeting of the Society for Cryobiology, reflecting her leadership in the field.

Editorial Board Member

Dr. Amorim is an editorial board member and associate editor for several prestigious journals, including Reproductive Biology and Endocrinology and Journal of Fertility Preservation, showcasing her expertise and influence in reproductive health research.

Ad-hoc Reviewer

She has reviewed articles for a wide range of scientific journals, such as Human Reproduction and Acta Biomaterialia, contributing significantly to the peer-review process in her field.

Grant Reviewer

Dr. Amorim has reviewed grants for organizations like the European Commission and the Deutsche Forschungsgemeinschaft, highlighting her role in advancing scientific research through rigorous evaluation.

Project Grants

She has been involved in several significant research projects, including the PROVIDE project on in vitro folliculogenesis and spermatogenesis, supported by substantial funding from various organizations.

Other Meriting Academic Missions

Dr. Amorim has delivered numerous invited talks at prestigious international conferences, sharing her research on reproductive tissue engineering and fertility preservation.

Awards/Recognition

Her contributions to science have been recognized with numerous awards, including being listed among the top 25 World Experts in Fertility by ExpertScape and as one of the top 2% scientists worldwide by Elsevier. She also received the 3M Award “25 Women in Science in Latin America” in 2021 and the Royan International Research Award for best research in Female Infertility in 2014.

Conclusion

With extensive academic qualifications, groundbreaking research in fertility and reproductive health, leadership roles, and numerous awards, Assoc. Prof. Dr. Christiani Amorim is an exemplary candidate for the Research for Hypothesis Achievement Award. Her innovative work and significant contributions to the field make her highly suitable for this honor.

research focus

Based on the research papers listed, the focus of this person’s research is on ovarian tissue cryopreservation, including methods for preserving and transplanting ovarian tissue. Their work covers various aspects, such as the safety and efficacy of reimplantation of cryopreserved ovarian tissue, vitrification techniques, and the survival of pre-antral follicles after cryopreservation. They have also explored the development of biodegradable scaffolds for ovarian cell transplantation and reviewed the progress of ovarian tissue banks. This research is crucial for female fertility preservation, particularly for patients undergoing treatments like chemotherapy. 🌟🧬❄️

Publication top notes

Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe

Vitrification as an alternative means of cryopreserving ovarian tissue

Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix

A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold

Transplantation of an alginate–matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles …

A review of 15 years of ovarian tissue bank activities

Cryopreservation of human ovarian tissue: a review

Vitrification and xenografting of human ovarian tissue

Cryopreservation of ovarian tissue: an emerging technology for female germline preservation of endangered species and breeds

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Prof Dr Gulali Aktas, Abant Izzet Baysal University Hospital, Turkey

Prof. Dr. Gulali Aktas is a dedicated physician with 24 years of experience in internal medicine. As an academician for 13 years, he has mentored countless medical students and contributed to significant research. He holds an MD and Associate Professorship from Abant Izzet Baysal University. His prolific work includes 183 international journal publications, 19 conference presentations, and 11 book chapters. Recognized for his excellence, he was nominated for the Raise the Line Faculty Award in 2022 and is listed in Stanford University’s top 2% scientists. Fluent in Turkish, English, and basic German, he champions patient-centered care and lifelong learning. 🏥📚🌟

Publication profile

google scholar

Education

Dr. Gulali Aktas is an Associate Professor of Internal Medicine since 2015. They completed their Internal Medicine residency (PhD equivalent) at Ondokuz Mayis University, Samsun, Turkey (2003-2008), and Pulmonology residency at Yedikule Training and Research Hospital, Istanbul, Turkey (2002-2003). They earned their MD from Ondokuz Mayis University in 2000. With 211 research contributions published in peer-reviewed journals and an impressive H-index of 35 (WoS), 42 (Google Scholar), and 36 (Scopus), Dr. Gulali Aktas is a prominent researcher. Fluent in Turkish, English, and basic German, they are known for their honesty, hard work, optimism, and foresight. 🌟📚🩺🌍

Experience

From 2011 to 2014, courses such as Dyspnea and Edema, Approach to Chest Pain, Fever and Hyperthermia, and Leukopenia and Leukocytosis were taught in the spring, while Chronic Leukemia, Aplastic Anemia and Myelodysplasia, and Principles of Blood Transfusion were covered in the autumn. Rheumatology topics like Anamnesis, Physical Examination, and Laboratory Test Analysis were emphasized. Other subjects included Familial Mediterranean Fever, Behcet’s Disease, Chronic Pancreatitis, Liver Cirrhosis, Esophageal Diseases, Colon Polyps, Celiac Disease, Chronic Viral and Non-Viral Hepatitis, and Mesenteric Ischemia. 🩺📚✨

Presentations

Dr. Gulali Aktaş has presented several notable studies. At the 30th World Congress of Endourology in 2012, his team discussed “Warfarin intoxication induced bilateral renal hematoma” (📚🩸). He compared surgical techniques for pylonidal sinus surgery and explored sleep quality in IBS patients at the XVI Annual European Society of Surgery (🔪💤). In 2013, at the 50th ERA-EDTA Congress, he highlighted the effects of nocturnal blood pressure on hemodialysis patients’ nutrition (🌙🩺). His research on metabolic syndrome, presented at the 10th Metabolic Syndrome Symposium, investigated platelet volume, epicardial adipose tissue, and non-alcoholic hepatosteatosis (🩸📈). At the 51st ERA-EDTA Congress, he examined atrial conduction in hemodialysis patients (❤️🩺).

Research focus

G Aktas focuses on the use of hematological and biochemical markers as diagnostic and prognostic tools in various medical conditions. His research includes studies on the neutrophil-to-lymphocyte ratio as an indicator for diabetic control in type 2 diabetes mellitus and Hashimoto’s thyroiditis. He also explores the predictive value of the uric acid to HDL cholesterol ratio for metabolic syndrome and diabetes control, as well as novel inflammatory markers derived from hemogram parameters in irritable bowel syndrome and COVID-19. His work aims to improve diagnostic accuracy and patient outcomes. 🩸🔬📊

Publication top notes

Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus

Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis

Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus

Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?

Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus

Diabetes control could through platelet-to-lymphocyte ratio in hemograms

Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

Could red cell distribution width be a marker in Hashimoto’s thyroiditis?

Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men

Hematological predictors of novel Coronavirus infection